← Back to Clinical Trials
Recruiting NCT06271785

NCT06271785 Prognostic Value of High-resolution Electrical Source Imaging on the Success of Pediatric Focal Epilepsy Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06271785
Status Recruiting
Phase
Sponsor University Hospital, Angers
Condition Epilepsy in Children
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2024-05-15
Primary Completion 2026-11-15

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
HR-EEG recording

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2024-05-15 with a primary completion date of 2026-11-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study investigates the usefulness of high resolution electrical source imaging (HR-ESI) in the setting of presurgical evaluation of drug-resistant focal epilepsy in children. This method is based on an estimation of the intra-cerebral source that produces a signal recorded by scalp electrodes by solving the inverse problem, taking into account attenuation factors resulting from particular conductivity properties of the cerebral, peri-cerebral and cranial tissues. Electrical sources are then fused on structural magnetic resonance imaging (MRI). Scalp EEG recorded using 64 to 256 electrodes refers to as high resolution EEG (HR-EEG), leading to HR-ESI. Studies based on small population of children or on mixt population of children and adults showed that HR-ESI has accuracy values, i.e. percentage of true positives (electrical source localized in the brain area resected and success of surgery) and true negatives (electrical source localized outside the brain area resected and failure of surgery) among the total population, ranging from 50 to 80%. Discrepancies between studies could be explained by the limited number of patients included or by the mixture of pediatric and adult data. Another limitation of previously published studies is that the spatial pattern of dipole source distribution was not taken into account to determine prediction accuracy of ESI. Studies using magnetoencephalography (MEG) to perform magnetic source imaging (MSI) suggest that the spatial pattern of dipole source distribution needs to be considered, a spatially-restricted dipole distribution being associated with better post-surgical outcome when resected. To tackle these issues, the investigators aim to conduct the first large prospective multicentric study in children with focal epilepsy candidates to surgery to assess prediction accuracy of ESI based on the finding of tight clusters of dipoles. This is original as this pattern (tight versus loose cluster of dipoles) has been studied by several researchers using MEG but not using HR-EEG. The investigators make the hypothesis that HR-EEG will allow to identity good candidates for epilepsy surgery and thus to offer this underutilized treatment in more children with better post-surgical outcome. Among the secondary objectives, the investigators will address methodological issues related to the resolution of the inverse problem (methods using distributed sources models versus methods based on equivalent dipole estimation), the potential added value to model high-frequency oscillations (HFO), and the investigators will assess the cost-utility of the HR-ESI procedure.

Eligibility Criteria

Inclusion Criteria: 1. Age≥2 and \<17 years; 2. Drug-resistant focal epilepsy (failure of at least 2 well-conducted drug trials); 3. Phase 1 pre-op evaluation with scalp video-EEG recording, MRI and PET-FDG suggesting that the patient could be a good candidate for epilepsy surgery; 4. Recent scalp EEG record (within 12 months) showing the presence of interictal spikes; 5. High-quality and recent (within 6 months) structural MRI with 3D-T1 sequences covering the whole brain and the scalp available. Exclusion Criteria: 1. Behavioral deficits making recording of scalp EEG impossible without sedation; 2. Informed consent form not signed by the parents; 3. Patient not affiliated to a social security system

Contact & Investigator

Central Contact

Patrick Van Bogaert, Professor

✉ Patrick.VanBogaert@chu-angers.fr

📞 +33 2 41 35 48 46

Frequently Asked Questions

Who can join the NCT06271785 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 17 Years, studying Epilepsy in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06271785 currently recruiting?

Yes, NCT06271785 is actively recruiting participants. Contact the research team at Patrick.VanBogaert@chu-angers.fr for enrollment information.

Where is the NCT06271785 trial being conducted?

This trial is being conducted at Angers, France, Lille, France, Lyon, France, Marseille, France and 5 additional locations.

Who is sponsoring the NCT06271785 clinical trial?

NCT06271785 is sponsored by University Hospital, Angers. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology